Research Project
Medical Cannabis Through Clinical Trials”
Thank you for applying for the
BioData Research Project.
Please check your email for the Informed Consent Form. Complete the Informed Consent Form to complete your application. After Submitting the Informed Consent Form we will review your details and send you an email letting you know whether your application has been successful or not.
Take me Back to the Home PageAbout the BIODATA
Research Project
A joint venture between Biodata (A Division of Labat Healthcare), Medical Cannabis SA and ONQ Clinical Research Organisation will commence a Research Project to develop relevant data in support of its future clinical trials for pain management, anxiety and sleep disorders. “It’s being called South Africa’s first real-world study of medical cannabis and researchers at Biodata, ONQ Clinical Research Organisation and Medical Cannabis SA predict that it will provide much-needed insight into the link between cannabis genetics and patient outcomes".
Led by Dr. Shiksha Gallow the Principal Investigator, the Medical Cannabis Real-World Evidence (MC-RWE) study will involve a minimum of 1,000 participants whose medical cannabis use will be observed over a period of time. It is further predicted that the research project will be extended to a significantly increased sample size to tens of thousands of patients should the initial results show a high level of success. Those in the study will be able to access a range of medical cannabis flower and oils that have consistent genetic, chemical, cannabinoid, and terpene profiles, which will address an ongoing issue with anecdotal evidence.
Biodata will conduct the research by way of a Crowd Funded Project and the aim is to create funding to support the costs of running the research program which will assist with creating substantial observational and case studies data and to fund the future Clinical Trials. The resultant outcome would be to ensure legal access to natural occurring medicines like Cannabis to the public as a whole.
All cannabis will be sourced from fully compliant South African Health Products Authority approved and licensed facilities.
Thank you for applying for the
BioData Research Project.
Please check your email for the Informed Consent Form. Complete the Informed Consent Form to complete your application. After Submitting the Informed Consent Form we will review your details and send you an email letting you know whether your application has been successful or not.
Take me Back to the Home PageAbout the BIODATA
Research Project
A joint venture between Biodata (A Division of Labat Healthcare), Medical Cannabis SA and ONQ Clinical Research Organisation will commence a Research Project to develop relevant data in support of its future clinical trials for pain management, anxiety and sleep disorders. “It’s being called South Africa’s first real-world study of medical cannabis and researchers at Biodata, ONQ Clinical Research Organization and Medical Cannabis SA predict that it will provide much-needed insight into the link between cannabis genetics and patient outcomes."
Led by Dr. Shiksha Gallow the Principal Investigator, the Medical Cannabis Real-World Evidence (MC-RWE) study will involve a minimum of 1,000 participants whose medical cannabis use will be observed over a period of time. It is further predicted that the research project will be extended to a significantly increased sample size to tens of thousands of patients should the initial results show a high level of success. Those in the study will be able to access a range of medical cannabis flower and oils that have consistent genetic, chemical, cannabinoid, and terpene profiles, which will address an ongoing issue with anecdotal evidence.
Biodata will conduct the research by way of a Crowd Funded Project and the aim is to create funding to support the costs of running the research program which will assist with creating substantial observational and case studies data and to fund the future Clinical Trials. The resultant outcome would be to ensure legal access to natural occurring medicines like Cannabis to the public as a whole.
All cannabis will be sourced from fully compliant South African Health Products Authority approved and licensed facilities.